Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)

Clinical trial NCT00086658 · COMPLETED

Trial details

NCT number: NCT00086658
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypereosinophilia Hypereosinophilic Syndrome

Start date: 2004-03-23
Primary completion: 2006-05-01
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.